By Drew Lindsay (The Chronicle of Philanthropy) – Largely forgotten in the fuss over Silicon Valley’s new wealth, New York philanthropy roars back from the recession.
By Eric S. Lander (Cell) – Three years ago, scientists reported that CRISPR technology can enable precise and efficient genome editing in living eukaryotic cells. Since then, the method has taken the scientific community by storm, with thousands of labs using it for applications from biomedicine to agriculture.
NEW YORK, Dec. 10, 2015 /PRNewswire/ — Kiva.org, the leading global microlending nonprofit, announced the launch of Kiva NYC, a new multi-year initiative to help level the playing field for lower-income small business owners in New York City.
What happens when you put 150 altruistic billionaires, legendary entertainers and Noble Prize-worthy gamechangers in one room for a day to talk about ways to give smart and better? Some disruptive ideas regarding philanthropy.
Said Business School and The Pershing Square Foundation announce Scholarship winners for Oxford 1+1 MBA, recognising outstanding individuals determined to solve global social challenges
By Paul Karon (Inside Philanthropy) – Philanthropists (and the foundations they establish) have an understandable bias toward results-oriented giving: people who achieve great success because they’re great at making things happen in the real world often want their philanthropy to be similarly productive.
By Amanda Gordon (Bloomberg Business) – Bill Ackman didn’t let an investor’s call he had to prepare for get in the way of a family celebration.
Over the last five years, the Pershing Square Foundation has benefited greatly by having a strong team of professionals led by Paul Bernstein, our CEO, who have been key partners with us as the Foundation’s programs and impact have grown. Paul will moving on to new initiatives outside the Foundation at year end.
By Paul Karon (Inside Philanthropy) – We report frequently enough about research grants and prizes specifically for young investigators—particularly in the biomedical sciences—that some readers have asked why so many foundations make it a point to earmark this early-career funding. What’s the obsession with youth? We gray-hairs want to know.